Annals of maxillofacial surgery · 2022
Chronic Invasive Aspergillosis with Fulminant Mucormycosis Sparing Palate in a Post-COVID-19 Patient - A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ramani Pratibha, Krishnan Reshma Poothakulath, Pandiar Deepak, Benitha J Georgia, Ramalingam Karthikeyan, Gheena S
Аннотация
RATIONALE: COVID-19 patients, especially immunocompromised or severely ill, have a higher probability of suffering from invasive fungal infections.
PATIENT CONCERNS: A 41-years-old male reported with pain and heaviness in the face for the past 20 days. Patient had tested COVID-19 positive 20 days back and was recently diagnosed with diabetes mellitus. On histopathological examination numerous hyphae resembling mucor and asper fungi were evident.
DIAGNOSIS: Chronic invasive aspergillosis with fulminant mucormycosis sparing palate.
TREATMENT: Since the lesion was spreading very rapidly the patient was referred to an isolation facility for further management.
OUTCOMES: We have postulated few hypothesis for the coinfection of aspergillosis and mucormycosis in our patient.
TAKE-AWAY LESSONS: It is important for the clinicians to systematically screen post COVID-19 patients for fungal infections, especially in immunocompromised and severely ill patients.
PATIENT CONCERNS: A 41-years-old male reported with pain and heaviness in the face for the past 20 days. Patient had tested COVID-19 positive 20 days back and was recently diagnosed with diabetes mellitus. On histopathological examination numerous hyphae resembling mucor and asper fungi were evident.
DIAGNOSIS: Chronic invasive aspergillosis with fulminant mucormycosis sparing palate.
TREATMENT: Since the lesion was spreading very rapidly the patient was referred to an isolation facility for further management.
OUTCOMES: We have postulated few hypothesis for the coinfection of aspergillosis and mucormycosis in our patient.
TAKE-AWAY LESSONS: It is important for the clinicians to systematically screen post COVID-19 patients for fungal infections, especially in immunocompromised and severely ill patients.